Spyre Therapeutics (SYRE) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: SYRE) | Delayed: 90.33 -2 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.33 | 52 Week High | $ | |||
| Open | $90.71 | 52 Week Low | $ | |||
| Day High | $91.90 | P/E | N/A | |||
| Day Low | $88.69 | EPS | $ | |||
| Volume | 503,101 | |||||
